Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

Hepatitis C virus core protein induces homotolerance and cross-tolerance to Toll-like receptor ligands by activation of Toll-like receptor 2.

Chung H, Watanabe T, Kudo M, Chiba T.

J Infect Dis. 2010 Sep 15;202(6):853-61. doi: 10.1086/655812.

PMID:
20677943
2.

Correlation between hyporesponsiveness to Toll-like receptor ligands and liver dysfunction in patients with chronic hepatitis C virus infection.

Chung H, Watanabe T, Kudo M, Chiba T.

J Viral Hepat. 2011 Oct;18(10):e561-7. doi: 10.1111/j.1365-2893.2011.01478.x. Epub 2011 May 25.

PMID:
21914077
3.

Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation.

Dolganiuc A, Oak S, Kodys K, Golenbock DT, Finberg RW, Kurt-Jones E, Szabo G.

Gastroenterology. 2004 Nov;127(5):1513-24.

PMID:
15521019
4.

Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins.

Chang S, Dolganiuc A, Szabo G.

J Leukoc Biol. 2007 Sep;82(3):479-87. Epub 2007 Jun 26.

PMID:
17595379
5.

Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.

Miyazaki M, Kanto T, Inoue M, Itose I, Miyatake H, Sakakibara M, Yakushijin T, Kakita N, Hiramatsu N, Takehara T, Kasahara A, Hayashi N.

J Med Virol. 2008 Jun;80(6):980-8. doi: 10.1002/jmv.21174.

PMID:
18428149
6.

Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma.

Feldmann G, Nischalke HD, Nattermann J, Banas B, Berg T, Teschendorf C, Schmiegel W, Dührsen U, Halangk J, Iwan A, Sauerbruch T, Caselmann WH, Spengler U.

Clin Cancer Res. 2006 Aug 1;12(15):4491-8.

7.

Circulating Toll-like receptor (TLR) 2, TLR4, and regulatory T cells in patients with chronic hepatitis C.

Wang JP, Zhang Y, Wei X, Li J, Nan XP, Yu HT, Li Y, Wang PZ, Bai XF.

APMIS. 2010 Apr;118(4):261-70. doi: 10.1111/j.1600-0463.2010.02586.x.

PMID:
20402671
8.

Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines.

Abe T, Kaname Y, Hamamoto I, Tsuda Y, Wen X, Taguwa S, Moriishi K, Takeuchi O, Kawai T, Kanto T, Hayashi N, Akira S, Matsuura Y.

J Virol. 2007 Sep;81(17):8953-66. Epub 2007 Jun 13.

9.

Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection.

Dolganiuc A, Chang S, Kodys K, Mandrekar P, Bakis G, Cormier M, Szabo G.

J Immunol. 2006 Nov 15;177(10):6758-68.

10.

Expression of Toll-like receptors in chronic hepatitis C virus infection.

Sato K, Ishikawa T, Okumura A, Yamauchi T, Sato S, Ayada M, Matsumoto E, Hotta N, Oohashi T, Fukuzawa Y, Kakumu S.

J Gastroenterol Hepatol. 2007 Oct;22(10):1627-32.

PMID:
17845690
11.

Hepatitis C virus core protein subverts the antiviral activities of human Kupffer cells.

Tu Z, Pierce RH, Kurtis J, Kuroki Y, Crispe IN, Orloff MS.

Gastroenterology. 2010 Jan;138(1):305-14. doi: 10.1053/j.gastro.2009.09.009. Epub 2009 Sep 19.

PMID:
19769973
12.

Subversion of plasmacytoid and myeloid dendritic cell functions in chronic HCV infection.

Szabo G, Dolganiuc A.

Immunobiology. 2005;210(2-4):237-47.

PMID:
16164031
13.

Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation.

Dolganiuc A, Kodys K, Kopasz A, Marshall C, Do T, Romics L Jr, Mandrekar P, Zapp M, Szabo G.

J Immunol. 2003 Jun 1;170(11):5615-24.

14.

Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.

Loré K, Betts MR, Brenchley JM, Kuruppu J, Khojasteh S, Perfetto S, Roederer M, Seder RA, Koup RA.

J Immunol. 2003 Oct 15;171(8):4320-8.

15.

Cell activation by synthetic lipopeptides of the hepatitis C virus (HCV)--core protein is mediated by toll like receptors (TLRs) 2 and 4.

Düesberg U, von dem Bussche A, Kirschning C, Miyake K, Sauerbruch T, Spengler U.

Immunol Lett. 2002 Nov 1;84(2):89-95.

PMID:
12270544
16.

Induction of tolerance to lipopolysaccharide and mycobacterial components in Chinese hamster ovary/CD14 cells is not affected by overexpression of Toll-like receptors 2 or 4.

Medvedev AE, Henneke P, Schromm A, Lien E, Ingalls R, Fenton MJ, Golenbock DT, Vogel SN.

J Immunol. 2001 Aug 15;167(4):2257-67.

17.

Decreased frequency of HCV core-specific peripheral blood mononuclear cells with type 1 cytokine secretion in chronic hepatitis C.

Lechmann M, Woitas RP, Langhans B, Kaiser R, Ihlenfeldt HG, Jung G, Sauerbruch T, Spengler U.

J Hepatol. 1999 Dec;31(6):971-8.

PMID:
10604568
18.

TLR2- and TLR4-mediated signals determine attenuation or augmentation of inflammation by acute alcohol in monocytes.

Oak S, Mandrekar P, Catalano D, Kodys K, Szabo G.

J Immunol. 2006 Jun 15;176(12):7628-35.

19.

Toll-like receptor 2 ligands activate human basophils for both IgE-dependent and IgE-independent secretion.

Bieneman AP, Chichester KL, Chen YH, Schroeder JT.

J Allergy Clin Immunol. 2005 Feb;115(2):295-301.

PMID:
15696084
20.

The induction of Toll-like receptor tolerance enhances rather than suppresses HIV-1 gene expression in transgenic mice.

Báfica A, Scanga CA, Equils O, Sher A.

J Leukoc Biol. 2004 Mar;75(3):460-6. Epub 2003 Dec 4.

PMID:
14657211

Supplemental Content

Support Center